These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25786362)

  • 21. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
    Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
    J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
    Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
    Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors.
    Wang AT; Liang DS; Liu YJ; Qi XR
    Biomaterials; 2015 Jun; 53():160-72. PubMed ID: 25890716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade.
    Mishra GP; Nguyen D; Alani AW
    Mol Pharm; 2013 May; 10(5):2071-8. PubMed ID: 23590802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
    Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.
    Sun TM; Du JZ; Yao YD; Mao CQ; Dou S; Huang SY; Zhang PZ; Leong KW; Song EW; Wang J
    ACS Nano; 2011 Feb; 5(2):1483-94. PubMed ID: 21204585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells.
    Wang B; Li S; Meng X; Shang H; Guan Y
    Tumour Biol; 2015 Aug; 36(8):6433-43. PubMed ID: 25801244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermoresponsive nanostructured polycarbonate block copolymers as biodegradable therapeutic delivery carriers.
    Kim SH; Tan JP; Fukushima K; Nederberg F; Yang YY; Waymouth RM; Hedrick JL
    Biomaterials; 2011 Aug; 32(23):5505-14. PubMed ID: 21529935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial.
    Robidoux A; Tang G; Rastogi P; Geyer CE; Azar CA; Atkins JN; Fehrenbacher L; Bear HD; Baez-Diaz L; Sarwar S; Margolese RG; Farrar WB; Brufsky AM; Shibata HR; Bandos H; Paik S; Costantino JP; Swain SM; Mamounas EP; Wolmark N
    Lancet Oncol; 2013 Nov; 14(12):1183-92. PubMed ID: 24095300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
    Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
    J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors.
    Zheng N; Dai W; Du W; Zhang H; Lei L; Zhang H; Wang X; Wang J; Zhang X; Gao J; Zhang Q
    Mol Pharm; 2012 May; 9(5):1175-88. PubMed ID: 22435704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity.
    Jorvig JE; Chakraborty A
    Anticancer Drugs; 2015 Feb; 26(2):160-6. PubMed ID: 25243457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
    Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
    Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.
    Song W; Tang Z; Li M; Lv S; Sun H; Deng M; Liu H; Chen X
    Acta Biomater; 2014 Mar; 10(3):1392-402. PubMed ID: 24316362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microtubule-stabilizing agents epothilones A and B and their desoxy-derivatives induce mitotic arrest and apoptosis in human prostate cancer cells.
    Sepp-Lorenzino L; Balog A; Su DS; Meng D; Timaul N; Scher HI; Danishefsky SJ; Rosen N
    Prostate Cancer Prostatic Dis; 1999 Jan; 2(1):41-52. PubMed ID: 12496865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.
    Jackson JK; Gleave ME; Yago V; Beraldi E; Hunter WL; Burt HM
    Cancer Res; 2000 Aug; 60(15):4146-51. PubMed ID: 10945622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.